Indefinite Delivery Contract 36C24925D0067

Award Date 5/20/25
Last Date to Order 5/20/29
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) to Miravista Diagnostics LLC, a for-profit limited liability company, for specialized reference laboratory testing services. The single-award IDC, valued at up to $240,445, was issued by the VA's Veterans Integrated Service Network 10 (VISN 10) to provide fungal and microbiology testing to support healthcare programs in Michigan and Indiana. Under this IDC, Miravista Diagnostics has received multiple delivery...
This indefinite delivery contract (IDC) 36C25024D0118 was awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 10, to Miravista Diagnostics LLC, a for-profit limited liability company that manufactures goods and provides clinical laboratory testing services. The contract, valued at $238,035, is for reference laboratory fungal testing services to support VA healthcare programs in Michigan and Indiana. It is a single-award IDC with a...
The subject contract is an Indefinite Delivery Contract (IDC) awarded by the U.S. Department of Veterans Affairs (VA) to Diasorin Inc., a foreign-owned, for-profit manufacturer of diagnostic testing equipment, assays, reagents, and related services. The contract has a total ceiling value of $291,245.30 and a period of performance through July 14, 2025. Under this IDC, Diasorin will provide the VA's VISN 17 network with its LIAISON XL analyzer reagents for a variety of infectious disease testing,...
The federal contract IDV award is for "BACTERIAL IDENTIFICATION AND SUSCEPTIBILITY TESTING" services, with the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 as the funding agency. The prime contractor is Becton, Dickinson and Company (BD), operating through its IDS division as BD Diagnostic Systems. The contract is a single-award Indefinite Delivery Contract with a ceiling value of $1,345,002.75 and an ultimate completion date of March 31, 2026. The contract...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) with a ceiling value of $179,584.05, awarded by the Veterans Integrated Service Network 4 (VISN 4), a civilian agency. The prime contractor is National Jewish Health, a non-profit hospital and research center based in Denver, Colorado. The IDC is focused on providing MYCOBACTERIUM LAB TESTING - OFF SITE services to the agency. This likely includes a range of specialized laboratory testing and diagnostic...
The federal contract IDV awarded to Medmira Laboratories Inc. is a Federal Supply Schedule (FSS) contract for in-vitro diagnostics, reagents, test kits, and test sets (FSS-65-VII). The $750,000.00 contract was awarded on Apr 15, 2025 by the Department of Veteran Affairs (VA) and has an ultimate completion date of Apr 14, 2030. As a multiple award FSS contract, Medmira Laboratories Inc. will provide the VA's Veterans Integrated Service Network 12 with a variety of in-vitro diagnostic products and...
The key products and services being delivered under this federal contract IDV award are in vitro diagnostic reagents, test kits, and related medical laboratory equipment and services. The prime contractor, Luminex Corporation, was awarded a Federal Supply Schedule (FSS) contract by the Department of Veterans Affairs (VA) to provide these specialized biological testing technologies and support services. Luminex's proprietary platforms, assays, and diagnostic solutions enable automated analysis of...
This federal contract IDV award is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA), Veterans Integrated Service Network 2 (VISN 2), to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at up to $6,557,011.80, covers the procurement of Biomerieux's proprietary BioFire Panels and Verification Kits for infectious disease testing and pathogen detection across VA healthcare operations. The contract does not have a set-aside...
The federal contract IDV award is a Blanket Purchase Agreement (BPA) issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 23 (VISN 23) to Fisher Scientific Company L.L.C.'s Fisher Healthcare division. The contract, valued at up to $245,875.99, provides for the delivery of Remel-branded media products, which are likely diagnostic testing reagents and consumables used in VA medical facilities for microbiological testing and infection diagnosis. The BPA is part of a...
The federal contract IDV award is for LAB TESTS FOR POST TRANSPLANT CARE, issued by the Department of Veterans Affairs (VA) to the prime contractor Caredx, Inc., a for-profit medical diagnostics company based in Brisbane, California. This is a single-award Indefinite Delivery Contract valued at $4,367,680.42 with a period of performance from April 1, 2025 to March 31, 2030. The contract aims to procure a range of specialized genetic and molecular testing services from Caredx, including the...
  • 36C24925D0067
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

This federal contract IDV award is for a Delivery Order contract between the Department of Veterans Affairs (VA) and Miravista Diagnostics LLC, a for-profit limited liability company specializing in clinical laboratory testing services, particularly fungal and microbiology diagnostic testing. The contract, valued at $462,375.00, was awarded on May 20, 2025, with a performance period through May 19, 2030.

Miravista Diagnostics LLC has previously been awarded several Indefinite Delivery Contracts (IDCs) with the VA, valued at $238,035 and $240,445, for reference laboratory fungal testing services and other specialized laboratory testing to support VA healthcare programs in Michigan and Indiana. The company has also received federal grant funding from the National Institute of Allergy and Infectious Diseases (NIAID) to develop innovative diagnostic tools for Coccidioidomycosis, an endemic mycosis. This Delivery Order contract does not have a set-aside designation, indicating Miravista Diagnostics' competitive capabilities in providing specialized laboratory services directly to federal agencies.

Generated 5/27/25, 9:50 AM